Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 421-430 of 682 for cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. DAREON™-5: A Study To Test Whether Different Doses Of BI 764532 Help People With Small Cell Lung Cancer Or Other Neuroendocrine Cancers

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Evaluating Changes In Quality Of Life After Near Margin-less Adaptive Radiation Therapy Compared To Standard Stereotactic Ablative Body Radiotherapy In Localized Prostate Cancer

    Albert Lea, MN, Eau Claire, WI, La Crosse, WI, Mankato, MN, Rochester, MN

  3. The Development, Safety, And Feasibility Of An Artificial Intelligence-Powered Platform (NodeAI) For Real-Time Prediction Of Mediastinal Lymph Node Malignancy During Endobronchial Ultrasound Staging For Lung Cancer

    Rochester, MN

  4. Axatilimab Plus Standard Of Care Therapy For The Prevention Of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Hematologic Cancer, ABRAXAS Trial

    Jacksonville, FL, Scottsdale/Phoenix, AZ, Rochester, MN

  5. High-dose Prophylactic Gabapentin (HOPE) Vs. Placebo To Prevent Opioid Use For Oral Mucositis Pain During Concurrent Chemoradiation For Head And Neck Cancer

    Albert Lea, MN, Scottsdale/Phoenix, AZ, Eau Claire, WI, La Crosse, WI, Mankato, MN, Rochester, MN

  6. A Clinical Trial Of Adjuvant Intismeran (V940) With Or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) In High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

    Jacksonville, FL, Rochester, MN

  7. A Study To Compare The Combination Of Navlimetostat (BMS-986504) With Pembrolizumab And Chemotherapy Versus Placebo Plus Pembrolizumab And Chemotherapy In First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. A Study Of Amivantamab In Combination With Lazertinib, Or Amivantamab In Combination With Platinum-Based Chemotherapy, For Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    Jacksonville, FL, Rochester, MN

  9. A Study To Assess Adverse Events And Change In Disease Activity In Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone Or With Standard Of Care In Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer And No Radiographic Evidence Of Disease

    Jacksonville, FL, Rochester, MN

  10. A Study Of Pirtobrutinib In Participants With Immune Thrombocytopenia

    Rochester, MN

.

Mayo Clinic Footer